Literature DB >> 25193287

Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue.

Kazuya Ishikawa1, Sayaka Yagi-Nakanishi1, Yosuke Nakanishi1, Satoru Kondo1, Akira Tsuji1, Kazuhira Endo1, Naohiro Wakisaka1, Shigeyuki Murono1, Tomokazu Yoshizaki2.   

Abstract

OBJECTIVE: The aim of this study was to clarify the role of IL-33 in tumor progression.
METHODS: Surgical specimens from 81 patients with squamous cell carcinoma of the tongue were studied using immunohistochemistry. Primary tumor sections were analyzed for IL-33 and ST2 expression. To examine the influence of IL-33 on the microenvironment of the tumor, we determined the mast cell density (MCD) and microvessel density of the stroma.
RESULTS: Patients with high IL-33 expression had a significantly worse prognosis (p=0.004). IL-33 expression was significantly elevated in patients with local and nodal recurrence (p=0.014 and p=0.019). ST2 expression was also associated with a worse prognosis (p=0.024) and was significantly elevated in patients with nodal recurrence (p=0.004). MCD was associated with worse prognosis (p=0.038) and correlated significantly with IL-33 expression (r=0.626, p<0.001). Micovessels in the stroma were significantly increased in the high IL-33 group (p<0.001).
CONCLUSION: These data suggest that the IL-33/ST2 axis contributes to tumor aggressiveness and affects the tumor microenvironment. Immunohistochemical evaluation of IL-33 and ST2 is useful for identifying patients at a high risk for poor prognosis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Interleukin-33; Malignant potential; Mast cell; ST2; Tongue squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25193287     DOI: 10.1016/j.anl.2014.08.007

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  16 in total

Review 1.  Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.

Authors:  Binfeng Lu; Min Yang; Qingqing Wang
Journal:  J Mol Med (Berl)       Date:  2016-02-27       Impact factor: 4.599

2.  Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.

Authors:  Xiaoguang Tong; Mark Barbour; Kezuo Hou; Chao Gao; Shuang Cao; Jingli Zheng; Yang Zhao; Rong Mu; Hui-Rong Jiang
Journal:  Mol Oncol       Date:  2015-09-09       Impact factor: 6.603

3.  Interleukin-33 and ST2 Signaling in Tumor Microenvironment.

Authors:  Jaewoo Hong; Soohyun Kim; P Charles Lin
Journal:  J Interferon Cytokine Res       Date:  2018-09-25       Impact factor: 2.607

Review 4.  The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.

Authors:  Marie-Hélène Wasmer; Philippe Krebs
Journal:  Front Immunol       Date:  2017-01-09       Impact factor: 7.561

5.  Decreased IL-33 Production Contributes to Trophoblast Cell Dysfunction in Pregnancies with Preeclampsia.

Authors:  Hong Chen; Xiaobo Zhou; Ting-Li Han; Philip N Baker; Hongbo Qi; Hua Zhang
Journal:  Mediators Inflamm       Date:  2018-03-15       Impact factor: 4.711

6.  ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate.

Authors:  Nádia Ghinelli Amôr; Carine Ervolino de Oliveira; Thaís Helena Gasparoto; Vanessa Garcia Vilas Boas; Graziela Perri; Ramon Kaneno; Vanessa Soares Lara; Gustavo Pompermaier Garlet; João Santana da Silva; Gislâine A Martins; Cory Hogaboam; Karen A Cavassani; Ana Paula Campanelli
Journal:  Oncotarget       Date:  2018-07-20

7.  Association between functional polymorphisms in IL-33/ST2 pathway and risk of osteosarcoma.

Authors:  Jun-Li Wang; Jia Liu; Ke-Gong Xie; Chang-Gong Lan; Lu Lu; Yu-Jin Tang
Journal:  J Cell Mol Med       Date:  2018-05-23       Impact factor: 5.295

Review 8.  The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.

Authors:  Mi-Ran Choi; Jeffrey A Sosman; Bin Zhang
Journal:  Cancers (Basel)       Date:  2021-06-30       Impact factor: 6.639

9.  High mast cell density indicates a longer overall survival in oral squamous cell carcinoma.

Authors:  Phillipp Brockmeyer; Alexander Kling; Xenia Schulz; Christina Perske; Henning Schliephake; Bernhard Hemmerlein
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

Review 10.  The Role of IL-33/ST2 Pathway in Tumorigenesis.

Authors:  Kristen M Larsen; Maydelis Karla Minaya; Vivek Vaish; Maria Marjorette O Peña
Journal:  Int J Mol Sci       Date:  2018-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.